XML 103 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Total
Reverse Recapitalization
At-the-Market Offering
July Public Offering
Conversion Of Convertible Preferred Stock
Conversion of Convertible Debt
Common Stock
Common Stock
Reverse Recapitalization
Common Stock
At-the-Market Offering
Common Stock
July Public Offering
Common Stock
Conversion Of Convertible Preferred Stock
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
Reverse Recapitalization
Additional Paid-in Capital
At-the-Market Offering
Additional Paid-in Capital
July Public Offering
Additional Paid-in Capital
Conversion Of Convertible Preferred Stock
Additional Paid-in Capital
Conversion of Convertible Debt
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2022 [1] 4,997,920                                      
Beginning balance at Dec. 31, 2022 [1] $ 111,060                                      
Balance at end of period (in shares) at Mar. 31, 2023 4,997,920                                      
Ending balance at Mar. 31, 2023 $ 111,060                                      
Balance at beginning of period (in shares) at Dec. 31, 2022 [1]             320,281                          
Beginning balance at Dec. 31, 2022 [1] (102,145)           $ 3         $ 0 $ 4,860           $ 0 $ (107,008)
Treasury stock, beginning balance (in shares) at Dec. 31, 2022 [1]                       0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Exercise of stock options (in shares)             4,699                          
Exercise of stock options 40                       40              
Issuance of common stock upon settlement of restricted stock units (in shares)             2,601                          
Issuance of common stock upon settlement of restricted stock units 34                       34              
Stock-based compensation 224                       224              
Net loss (8,029)                                     (8,029)
Balance at end of period (in shares) at Mar. 31, 2023             327,581                          
Ending balance at Mar. 31, 2023 $ (109,876)           $ 3         $ 0 5,158           0 (115,037)
Treasury stock, ending balance (in shares) at Mar. 31, 2023                       0                
Balance at beginning of period (in shares) at Dec. 31, 2022 [1] 4,997,920                                      
Beginning balance at Dec. 31, 2022 [1] $ 111,060                                      
Balance at end of period (in shares) at Sep. 30, 2023 0                                      
Ending balance at Sep. 30, 2023 $ 0                                      
Balance at beginning of period (in shares) at Dec. 31, 2022 [1]             320,281                          
Beginning balance at Dec. 31, 2022 [1] (102,145)           $ 3         $ 0 4,860           0 (107,008)
Treasury stock, beginning balance (in shares) at Dec. 31, 2022 [1]                       0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Foreign currency translation adjustment (25)                                      
Net loss (26,246)                                      
Balance at end of period (in shares) at Sep. 30, 2023             8,378,361                          
Ending balance at Sep. 30, 2023 $ 13,286           $ 84         $ (150) 146,631           (25) (133,254)
Treasury stock, ending balance (in shares) at Sep. 30, 2023                       (14,455)                
Balance at beginning of period (in shares) at Mar. 31, 2023 4,997,920                                      
Beginning balance at Mar. 31, 2023 $ 111,060                                      
Increase (Decrease) in Temporary Equity [Roll Forward]                                        
Conversion of preferred stock (in shares) (4,997,920)                                      
Conversion of preferred stock $ (111,060)                                      
Balance at end of period (in shares) at Jun. 30, 2023 0                                      
Ending balance at Jun. 30, 2023 $ 0                                      
Balance at beginning of period (in shares) at Mar. 31, 2023             327,581                          
Beginning balance at Mar. 31, 2023 (109,876)           $ 3         $ 0 5,158           0 (115,037)
Treasury stock, beginning balance (in shares) at Mar. 31, 2023                       0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Exercise of stock options (in shares)             4,460                          
Issuance of common stock upon settlement of restricted stock units (in shares)             903 26,550                        
Issuance of common stock upon settlement of restricted stock units 11 $ 27           $ 1         11 $ 26            
Conversion of convertible notes (in shares)                     4,997,920                  
Conversion of convertible notes         $ 111,060 $ 10,028         $ 50           $ 111,010 $ 10,028    
Issuance of common stock, net of issuance costs (in shares)             3,012,854                          
Issuance of common stock, net of issuance costs 19,739           $ 30           19,709              
Return of common stock to pay withholding taxes on restricted stock (in shares)                       (14,455)                
Return of common stock to pay withholding taxes on restricted stock (150)                     $ (150)                
Stock-based compensation 279                       279              
Foreign currency translation adjustment (2)                                   (2)  
Net loss (7,559)                                     (7,559)
Balance at end of period (in shares) at Jun. 30, 2023             8,370,268                          
Ending balance at Jun. 30, 2023 23,557           $ 84         $ (150) 146,221           (2) (122,596)
Treasury stock, ending balance (in shares) at Jun. 30, 2023                       (14,455)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Stock issuance costs $ 2,400                                      
Balance at end of period (in shares) at Sep. 30, 2023 0                                      
Ending balance at Sep. 30, 2023 $ 0                                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Exercise of stock options (in shares)             7,190                          
Exercise of stock options 60                       60              
Issuance of common stock upon settlement of restricted stock units (in shares)             903                          
Issuance of common stock upon settlement of restricted stock units 11                       11              
Stock-based compensation 339                       339              
Foreign currency translation adjustment (23)                                   (23)  
Net loss (10,658)                                     (10,658)
Balance at end of period (in shares) at Sep. 30, 2023             8,378,361                          
Ending balance at Sep. 30, 2023 $ 13,286           $ 84         $ (150) 146,631           (25) (133,254)
Treasury stock, ending balance (in shares) at Sep. 30, 2023                       (14,455)                
Balance at beginning of period (in shares) at Dec. 31, 2023 0                                      
Beginning balance at Dec. 31, 2023 $ 0                                      
Balance at end of period (in shares) at Mar. 31, 2024 0                                      
Ending balance at Mar. 31, 2024 $ 0                                      
Balance at beginning of period (in shares) at Dec. 31, 2023 9,603,723           9,603,723                          
Beginning balance at Dec. 31, 2023 $ 11,373           $ 96         $ (150) 153,827           (197) (142,203)
Treasury stock, beginning balance (in shares) at Dec. 31, 2023 (14,455)                     (14,455)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Issuance of common stock, net of issuance costs (in shares)             615,363                          
Issuance of common stock, net of issuance costs $ 5,062           $ 6           5,056              
Issuance of common stock upon settlement of restricted stock units (in shares)             903                          
Issuance of common stock upon settlement of restricted stock units 11                       11              
Stock-based compensation 324                       324              
Foreign currency translation adjustment (73)                                   (73)  
Net loss (11,827)                                     (11,827)
Balance at end of period (in shares) at Mar. 31, 2024             10,219,989                          
Ending balance at Mar. 31, 2024 4,870           $ 102         $ (150) 159,218           (270) (154,030)
Treasury stock, ending balance (in shares) at Mar. 31, 2024                       (14,455)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Stock issuance costs $ 103                                      
Balance at beginning of period (in shares) at Dec. 31, 2023 0                                      
Beginning balance at Dec. 31, 2023 $ 0                                      
Balance at end of period (in shares) at Sep. 30, 2024 0                                      
Ending balance at Sep. 30, 2024 $ 0                                      
Balance at beginning of period (in shares) at Dec. 31, 2023 9,603,723           9,603,723                          
Beginning balance at Dec. 31, 2023 $ 11,373           $ 96         $ (150) 153,827           (197) (142,203)
Treasury stock, beginning balance (in shares) at Dec. 31, 2023 (14,455)                     (14,455)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Exercise of stock options (in shares) 8,744                                      
Foreign currency translation adjustment $ (5)                                      
Net loss $ (37,894)                                      
Balance at end of period (in shares) at Sep. 30, 2024 10,784,377           10,784,377                          
Ending balance at Sep. 30, 2024 $ (18,986)           $ 108         $ (150) 161,355           (202) (180,097)
Treasury stock, ending balance (in shares) at Sep. 30, 2024 (14,455)                     (14,455)                
Balance at beginning of period (in shares) at Mar. 31, 2024 0                                      
Beginning balance at Mar. 31, 2024 $ 0                                      
Balance at end of period (in shares) at Jun. 30, 2024 0                                      
Ending balance at Jun. 30, 2024 $ 0                                      
Balance at beginning of period (in shares) at Mar. 31, 2024             10,219,989                          
Beginning balance at Mar. 31, 2024 4,870           $ 102         $ (150) 159,218           (270) (154,030)
Treasury stock, beginning balance (in shares) at Mar. 31, 2024                       (14,455)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Exercise of stock options (in shares)             3,391                          
Exercise of stock options 13                       13              
Issuance of common stock, net of issuance costs (in shares)             34,816                          
Issuance of common stock, net of issuance costs 303           $ 1           302              
Issuance of common stock upon settlement of restricted stock units (in shares)             677                          
Issuance of common stock upon settlement of restricted stock units 9                       9              
Stock-based compensation 350                       350              
Foreign currency translation adjustment 32                                   32  
Net loss (7,229)                                     (7,229)
Balance at end of period (in shares) at Jun. 30, 2024             10,258,873                          
Ending balance at Jun. 30, 2024 (1,652)           $ 103         $ (150) 159,892           (238) (161,259)
Treasury stock, ending balance (in shares) at Jun. 30, 2024                       (14,455)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Stock issuance costs $ 6                                      
Balance at end of period (in shares) at Sep. 30, 2024 0                                      
Ending balance at Sep. 30, 2024 $ 0                                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Exercise of stock options (in shares)             5,353                          
Exercise of stock options 21                       21              
Issuance of common stock, net of issuance costs (in shares)                 9,803 510,000                    
Issuance of common stock, net of issuance costs     $ 48 $ 1,080           $ 5         $ 48 $ 1,075        
Issuance of common stock upon settlement of restricted stock units (in shares)             348                          
Issuance of common stock upon settlement of restricted stock units 5                       5              
Stock-based compensation 314                       314              
Foreign currency translation adjustment 36                                   36  
Net loss $ (18,838)                                     (18,838)
Balance at end of period (in shares) at Sep. 30, 2024 10,784,377           10,784,377                          
Ending balance at Sep. 30, 2024 $ (18,986)           $ 108         $ (150) $ 161,355           $ (202) $ (180,097)
Treasury stock, ending balance (in shares) at Sep. 30, 2024 (14,455)                     (14,455)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Stock issuance costs     $ 1 $ 517                                
[1] Retroactively restated for the reverse recapitalization as described in Note 3.